Alexander I. Spira, Stanley R. Frankel, Siqing Fu, Syed Mohammad Ali Kazmi, Abdul Rafeh Naqash, Xinhua Zhu, Abhishek Tripathi, Alice Hsu, Julie Ahn, Douglas W. Orr, John B. Mumm. "Phase 1 study of DK2
            <sup>10</sup>
            (EGFR), a tumor-targeted IL2 x IL10 dual immunocytokine, in advanced cancer patients: Dose escalation, immune activation, and safety results.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.2589